Predictors of Anticoagulation Control on Warfarin Therapy

Completed

Conditions studied: Atrial Fibrillation, Deep Vein Thrombosis, Heart Valve Replacement

In brief

The goal of this research study is to develop better dosing of anticoagulation medication in both Caucasian and African Americans through analysis of various genetic factors.

Key facts

Study ID

NCT00905177

Run by

University of Pennsylvania

People needed

687

Starts

2009-06-01

Expected to finish

2013-08-01

Last updated by the study team

2016-05-20

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All Caucasians and African Americans who are new to warfarin therapy

You may not qualify if…

• Under 21 years of age
• Non caucasian
• Non african american
• Have an abnormal INR before warfarin or heparin therapy
• Unable to provide consent

Where it is running

• Hospital of the University of Pennsylvania, Anticoagulation Management Center — Philadelphia, Pennsylvania, United States
• Philadelphia Veteran Affairs Medical Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.